Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05221255
Other study ID # 0305398
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2022
Est. completion date October 1, 2022

Study information

Verified date May 2024
Source University of Alexandria
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

conservative management of functional constipation is a preferable method including biofeedback and spinal magnetic stimulation sessions


Description:

Constipation varies in presentation and severity among patients and affects patients' quality of life of varied degrees depending on how it manifests and how severe it is. The prevalence of constipation in the general population is estimated to affect about 20% of the population Spinal Magnetic Stimulation (SMS) is a non-invasive, painless neurophysiological treatment that uses extracorporeal magnetic stimulation to direct extracorporeal magnetic stimulation to the spinal nerves and deep muscles to aid bowl evacuation without the use of surgery. This noninvasive approach was created to help with micturition, expiration, and bowel function The aim of this work is to study the efficacy of SMS and biofeedback versus biofeedback in the management of functional constipation.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date October 1, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adults patients diagnosed by Rome IV criteria as having functional constipation Exclusion Criteria: - Patients younger than 18 years old. - Patients with irritable bowel syndrome. - Anal hemorrhoids or bleeding. - Any condition that may complicate bowel problems, such as Parkinson's disease, stroke, or traumatic brain injury.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
spinal magnetic stimulation
Biofeedback pelvic floor muscle training sessions will be performed for both groups for a total of 12 sessions. Menstruating women will be temporarily withdrawn from BF sessions till end of the menses. The session will last for 30 minutes of transrectal pressure biofeedback relaxation technique. Auditory and visual feedback will be provided in addition to positive verbal reinforcement. Sham SMS will be used in the Sham group using the placebo program in the magnetic stimulation machine. Spinal magnetic stimulation using the Neuro-MS/D machine. It will be used in spinal magnetic stimulation group, circular coil will be used to stimulate S2,3 and 4 sacral roots. Intensities will be adjusted to 50-70 % of maximal output (2.2 Tesla), stimulation frequency will be fixed at 20 Hz, burst length = 5 seconds, inter-burst interval = 25 seconds.

Locations

Country Name City State
Egypt Nehad ElShatby Alexandria

Sponsors (1)

Lead Sponsor Collaborator
University of Alexandria

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of weekly bowel movement Mean weekly complete spontaneous bowel movements. after 15 days
Primary The Bristol Stool Scale (from 1 to 5) Stool consistency After 15 days
Primary Numerical rating scale (from 0 to 10) pain assessment, zero indicates no pain, 10 indicates maximum pain degree After 15 days
Primary Patient Assessment of Constipation Quality of Life questionnaire Assessment of quality of life (from 9 to 127) lower scores indicating fewer problems After 15 days
Primary pressure manometry Assessment of pelvic floor power of contraction After 15 days
Secondary Number of weekly bowel movement Mean weekly complete spontaneous bowel movements. after one month
Secondary The Bristol Stool Scale (from 1 to 5) Stool consistency After one month
Secondary Numerical rating scale (from 0 to 10) pain assessment, zero indicates no pain, 10 indicates maximum pain degree After one month
Secondary Patient Assessment of Constipation Quality of Life questionnaire Assessment of quality of life (from 9 to 127) lower scores indicating fewer problems After one month
Secondary Pressure manometry Assessment of pelvic floor power of contraction After one month
See also
  Status Clinical Trial Phase
Completed NCT04506801 - The Effect of Probiotics on Functional Constipation in the Elderly N/A
Completed NCT04620161 - A Proof of Concept Study of Pradigastat in Patients With Functional Constipation Phase 2
Active, not recruiting NCT02361749 - Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation Phase 4
Completed NCT03054805 - The Effect of Probiotics on Constipation, and Intestinal Microflora in Children With Functional Constipation Phase 4
Not yet recruiting NCT01913665 - The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation N/A
Completed NCT01622972 - Mode of Action of Moviprep Phase 4
Completed NCT01348152 - Effect of TU-100 in Patients With Functional Constipation Phase 2
Completed NCT01212146 - Probiotic-enriched Artichoke in Functional Constipation N/A
Completed NCT04231162 - Effect of an 8-week Bifidobacterium Lactis HN019 Supplementation on Functional Constipation N/A
Not yet recruiting NCT03639142 - Dried Plums (Prunes) vs. Polyethylene Glycol 4000 for Treatment of Functional Constipation in Children Phase 3
Recruiting NCT04918329 - Functional Digestive Disorders Observatory
Completed NCT02592200 - Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy Women N/A
Completed NCT03707002 - Effect of scFOS on Increase in Stool Frequency in Constipated People N/A
Recruiting NCT06083311 - The Efficacy of a Probiotic for Functional Constipation (FC) N/A
Completed NCT04110145 - Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation Phase 2
Recruiting NCT06196073 - Visceral Osteopathy in Functional Constipation N/A
Completed NCT04026113 - Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) Phase 3
Completed NCT02359396 - A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics Phase 1
Completed NCT01847950 - Effects of scFOS on Stool Frequency in People With Functionnal Constipation N/A
Recruiting NCT01274793 - Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy Phase 1